Alector Inc (ALEC)
4.91
-0.22
(-4.20%)
USD |
NASDAQ |
Nov 14, 16:00
4.905
0.00 (0.00%)
After-Hours: 20:00
Alector Cash from Investing (Quarterly): 40.35M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 40.35M |
June 30, 2024 | 37.15M |
March 31, 2024 | -11.76M |
December 31, 2023 | 18.07M |
September 30, 2023 | 16.96M |
June 30, 2023 | -21.82M |
March 31, 2023 | 88.70M |
December 31, 2022 | 18.38M |
September 30, 2022 | 60.53M |
June 30, 2022 | -225.82M |
March 31, 2022 | -12.11M |
December 31, 2021 | -146.75M |
September 30, 2021 | -69.05M |
June 30, 2021 | 56.59M |
Date | Value |
---|---|
March 31, 2021 | 109.55M |
December 31, 2020 | 11.55M |
September 30, 2020 | 33.01M |
June 30, 2020 | -24.74M |
March 31, 2020 | -124.87M |
December 31, 2019 | 30.06M |
September 30, 2019 | 45.91M |
June 30, 2019 | 26.42M |
March 31, 2019 | -151.26M |
December 31, 2018 | 42.46M |
September 30, 2018 | -46.95M |
June 30, 2018 | -40.12M |
March 31, 2018 | -179.52M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-225.82M
Minimum
Jun 2022
109.55M
Maximum
Mar 2021
-5.801M
Average
17.52M
Median
Cash from Investing (Quarterly) Benchmarks
Precision BioSciences Inc | -0.064M |
NovaBay Pharmaceuticals Inc | -0.002M |
Palatin Technologies Inc | -0.0049M |
iBio Inc | -0.144M |
Theriva Biologics Inc | -0.001M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -50.73M |
Free Cash Flow | -222.26M |
Free Cash Flow Per Share (Quarterly) | -0.5224 |
Free Cash Flow to Equity (Quarterly) | -50.95M |
Free Cash Flow to Firm (Quarterly) | -50.95M |
Free Cash Flow Yield | -48.62% |